
Patients will be empowered to choose where they receive their NHS care under new plans to help cut waiting lists, one of the Prime Minister’s five priorities.
The Primary Care Respiratory Society (PCRS) advocates for the improvement of care and outcomes for people with respiratory diseases, bringing together all healthcare professionals, offering them a welcoming, supportive, inclusive, non-hierarchical community where everybody has a voice.
A consensus-based article that sets out a simple treatment pathway based on the predominant characteristics
Step by step guides, podcasts and webinars cover prevention, diagnosis, testing and management. They will help you to support your patients and improve their outcomes.
Inhaler devices may seem simple to use but they are often used incorrectly by patients and healthcare professionals alike.
The mMRC (Modified Medical Research Council) Dyspnoea Scale is used to assess the degree of baseline functional disability due to dyspnoea.
Our members' magazine packed with useful features, clinical updates, educational updates, respiratory news and opinion.
The asthma slide rule helps to start a conversation with your patients and/or colleagues around how much salbutamol is acceptable before a review is necessary
The RSF helps those looking to design a patient focussed respiratory service working across all sectors of out of hospital care
The UK's leading respiratory conference for clinicians working primary, community and integrated care comes to Telford in September.
Become part of the UK's largest network of dedicated respiratory professionals working in primary, community and integrated care settings
25th May 2023
Patients will be empowered to choose where they receive their NHS care under new plans to help cut waiting lists, one of the Prime Minister’s five priorities.
24th May 2023
This week the BBC reported on the results of laboratory tests conducted on vapes confiscated from a school in Kidderminster.
27th April 2023
March 2023 saw the first approval of a combination inhaled corticosteroid + long-acting beta2-agonist inhaler for the management of mild asthma in people over 12 years of age. The approval supports the move away from reliance on short-acting beta2-agonists which fa
Practice NursePCRS is an ideal forum for busy doctors and nurses in primary care with newsletters, treatment summaries and great training videos for the whole team.
England